Author

T. Else

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. A. Apfelbaum· 1 shared A. C. Latronico· 1 shared A. L. Solon· 1 shared A. M. Lerario· 1 shared A. Wakamatsu· 1 shared B. B. Mendonca· 1 shared B. L. Witten· 1 shared B. M. P. Mariani· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. A. Apfelbaum

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Spatial profiling of neuro-immune interactions in gastroenteropancreatic NETs

S. Duan, T. W. Sawyer, B. L. Witten, H. Song, T. Else, J. L. Merchant

This study uses spatial protein profiling to identify tissue-specific neuro-immune signatures in GEP-NETs, showing that duodenal gastrinomas express immune and pro-inflammatory factors that influence neuroendocrine traits.

bioRxiv · Jul 1, 2023 · PreprintCancer Biology

β-catenin programs a tissue-specific epigenetic vulnerability in aggressive adrenocortical carcinoma

D. R. Mohan, K. S. Borges, I. Finco, C. R. LaPensee, J. Rege, A. L. Solon, D. W. Little, T. Else, M. Q. Almeida, D. Dang, J. Haggerty-Skeans, A. A. Apfelbaum, M. Vinco, A. Wakamatsu, B. M. P. Mariani, , G. D. Hammer

This study shows that β-catenin maintains adrenocortical carcinoma differentiation through chromatin and histone interactions, and that targeting EZH2 can disrupt this process and inhibit tumor growth.

bioRxiv · Jul 2, 2022 · PreprintCancer Biology